Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1986
A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigenB G Sahagan, H Dorai, J Saltzgaber-Muller, et al.
Gastroenterology|December 1, 1986
Randomized trial of chlorambucil for primary biliary cirrhosisJ H Hoofnagle, G L Davis, D F Schafer, et al.
The Journal of Infectious Diseases|February 1, 1995
Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United StatesJ Y Lau, M Mizokami, J A Kolberg, et al.
Journal of Medical Virology|May 1, 1997
Detection of GB virus-C/hepatitis G virus RNA in serum by reverse transcription polymerase chain reactionB Bhardwaj, K Qian, J Detmer, et al.
Transplantation|September 1, 1993
Relationship of the polymerase chain reaction for cytomegalovirus to the development of hepatitis in liver transplant recipientsM A Wolff, K H Rand, H J Houck, et al.
Journal of Medical Virology|February 1, 1985
Treatment of chronic type B hepatitis with multiple ten-day courses of adenine arabinoside monophosphateJ H Hoofnagle, G L Davis, R G Hanson, et al.
Genetics|July 2, 1999
A maize map standard with sequenced core markers, grass genome reference points and 932 expressed sequence tagged sites (ESTs) in a 1736-locus mapG L Davis, M D McMullen, C Baysdorfer, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 5, 2011
Limiting hepatitis C virus progression in liver transplant recipients using sirolimus-based immunosuppressionG J McKenna, J F Trotter, E Klintmalm, et al.
Alimentary Pharmacology & Therapeutics|December 18, 2007
Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis CJ G McHutchison, K Patel, E R Schiff, et al.
Journal of Viral Hepatitis|November 22, 2014
Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trialM Buti, R Flisiak, J-H Kao, et al.
Pageof 17